KIF1A

SEPTEMBER 2, 2023

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. 2023 KAND Family & Scientific Engagement Conference Wrap-up A happy Labor Day weekend to our readers in the US!

Disease 111

Disease Science Research Trials 111

Drugs.com

SEPTEMBER 2, 2023

SATURDAY, Sept. 2, 2023 -- It can be hard for new college students, or those returning after summer break, to be away from home. Homesickness is a normal reaction. About 30% of all students and 70% of first-year students experience it. Though it can.

98

98

Covalent Modifiers

SEPTEMBER 2, 2023

Pasquale A. Morese, Nahoum Anthony, Michael Bodnarchuk, Claire Jennings, Mathew P. Martin, Richard A. Noble, Nicole Phillips, Huw D. Thomas, Lan Z. Wang, Andrew Lister, Martin E. M. Noble, Richard A. Ward, Stephen R. Wedge, Hannah L. Stewart, and Michael J. Waring Journal of Medicinal Chemistry 2023 DOI: 10.1021/acs.jmedchem.3c00845 A major drawback of cytotoxic chemotherapy is the lack of selectivity toward noncancerous cells.

Research 65

Research Drugs 65

Drug Patent Watch

SEPTEMBER 2, 2023

QUTENZA (capsaicin) Averitas Patent: 10,869,827 Expiration: Sep 5, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit… The post Drug Patent Expirations for the Week of September 3, 2023 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 64

Drugs Pharmaceuticals 64

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drug Patent Watch

SEPTEMBER 2, 2023

This chart shows the pharmaceutical companies with the most tentative generic drug approvals in 2022 The Food and Drug Administration (FDA) grants tentative approvals to generic entrants when their generic… The post Generic companies with the most tentative approvals appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 59

Pharmaceutical Companies FDA Pharmaceuticals Drugs 59